| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 23 | 2021 | 771 | 3.260 |
Why?
|
| Interferon Regulatory Factors | 11 | 2025 | 77 | 2.940 |
Why?
|
| Plasma Cells | 8 | 2025 | 88 | 2.360 |
Why?
|
| Cell Differentiation | 16 | 2025 | 1666 | 1.310 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2020 | 151 | 1.280 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 321 | 1.270 |
Why?
|
| Transplantation Tolerance | 4 | 2020 | 143 | 0.940 |
Why?
|
| Immunoglobulin M | 1 | 2025 | 165 | 0.870 |
Why?
|
| Germinal Center | 4 | 2021 | 65 | 0.820 |
Why?
|
| Immunologic Memory | 6 | 2023 | 188 | 0.770 |
Why?
|
| Antibody Formation | 2 | 2020 | 181 | 0.710 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 69 | 0.690 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 2059 | 0.640 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 1999 | 111 | 0.630 |
Why?
|
| Mice | 28 | 2025 | 12538 | 0.560 |
Why?
|
| Transcription Factors | 9 | 2020 | 1730 | 0.540 |
Why?
|
| Animals | 38 | 2025 | 28914 | 0.530 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 6 | 2025 | 16 | 0.520 |
Why?
|
| Graft Rejection | 7 | 2017 | 1126 | 0.480 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 74 | 0.460 |
Why?
|
| Signal Transduction | 9 | 2020 | 3581 | 0.460 |
Why?
|
| Repressor Proteins | 5 | 2006 | 447 | 0.450 |
Why?
|
| Heart Transplantation | 6 | 2017 | 812 | 0.400 |
Why?
|
| Isoantibodies | 5 | 2020 | 127 | 0.390 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2021 | 120 | 0.380 |
Why?
|
| Immunoglobulin Class Switching | 3 | 2022 | 40 | 0.380 |
Why?
|
| Organ Transplantation | 2 | 2015 | 298 | 0.360 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2011 | 8 | 0.360 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 488 | 0.350 |
Why?
|
| Antibody Diversity | 1 | 2011 | 25 | 0.350 |
Why?
|
| Genes, Immunoglobulin | 1 | 2011 | 111 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 13 | 2025 | 3489 | 0.330 |
Why?
|
| Graft Survival | 5 | 2017 | 942 | 0.320 |
Why?
|
| T-Lymphocytes | 6 | 2020 | 1316 | 0.310 |
Why?
|
| Antigens | 3 | 2017 | 231 | 0.300 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 1645 | 0.300 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 810 | 0.290 |
Why?
|
| Immune Tolerance | 1 | 2011 | 385 | 0.290 |
Why?
|
| Immunoglobulins | 3 | 2013 | 144 | 0.290 |
Why?
|
| PAX5 Transcription Factor | 2 | 2012 | 33 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 1124 | 0.260 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 667 | 0.250 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 1267 | 0.250 |
Why?
|
| Cell Lineage | 3 | 2016 | 324 | 0.250 |
Why?
|
| Viral Envelope Proteins | 2 | 1998 | 95 | 0.250 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1533 | 0.250 |
Why?
|
| T-Lymphocyte Subsets | 3 | 1998 | 290 | 0.240 |
Why?
|
| Abatacept | 2 | 2016 | 88 | 0.240 |
Why?
|
| Recombination, Genetic | 2 | 2022 | 444 | 0.240 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 995 | 0.240 |
Why?
|
| Th2 Cells | 2 | 2020 | 151 | 0.240 |
Why?
|
| Cytidine Deaminase | 4 | 2022 | 43 | 0.240 |
Why?
|
| Endosomes | 2 | 2017 | 86 | 0.230 |
Why?
|
| Polyadenylation | 1 | 2025 | 12 | 0.230 |
Why?
|
| CTLA-4 Antigen | 2 | 2016 | 145 | 0.210 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2004 | 42 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 1 | 2025 | 264 | 0.200 |
Why?
|
| Ribonucleases | 1 | 2022 | 97 | 0.190 |
Why?
|
| Mice, Knockout | 5 | 2017 | 2161 | 0.190 |
Why?
|
| Dendritic Cells | 4 | 2020 | 541 | 0.180 |
Why?
|
| Isoantigens | 2 | 2020 | 72 | 0.180 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2020 | 188 | 0.180 |
Why?
|
| Ikaros Transcription Factor | 1 | 2020 | 25 | 0.170 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 19 | 0.160 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2017 | 173 | 0.160 |
Why?
|
| Allografts | 3 | 2015 | 207 | 0.150 |
Why?
|
| Antigen Presentation | 3 | 1998 | 229 | 0.150 |
Why?
|
| Th17 Cells | 1 | 2020 | 97 | 0.150 |
Why?
|
| Peptide Fragments | 2 | 2012 | 477 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2025 | 2090 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1346 | 0.140 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 305 | 0.140 |
Why?
|
| Chromatin | 1 | 2021 | 446 | 0.140 |
Why?
|
| CD79 Antigens | 1 | 2017 | 17 | 0.140 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 13 | 0.140 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 49 | 0.130 |
Why?
|
| Encephalitis, Viral | 1 | 1997 | 7 | 0.130 |
Why?
|
| Ubiquitination | 1 | 2017 | 81 | 0.130 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1191 | 0.130 |
Why?
|
| Immunization | 1 | 2017 | 165 | 0.130 |
Why?
|
| Simplexvirus | 2 | 1997 | 150 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 327 | 0.130 |
Why?
|
| Interleukin-2 | 1 | 2017 | 248 | 0.130 |
Why?
|
| Kidney Transplantation | 2 | 2014 | 882 | 0.130 |
Why?
|
| Humans | 19 | 2022 | 96093 | 0.120 |
Why?
|
| Herpesvirus 1, Human | 1 | 1998 | 245 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1754 | 0.120 |
Why?
|
| Protein Binding | 2 | 2017 | 1560 | 0.120 |
Why?
|
| Protein Conformation | 1 | 1998 | 935 | 0.120 |
Why?
|
| Proteins | 1 | 2021 | 816 | 0.120 |
Why?
|
| Herpes Simplex | 1 | 1997 | 203 | 0.120 |
Why?
|
| Cell Line | 2 | 2017 | 2533 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2016 | 131 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 432 | 0.110 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2022 | 33 | 0.110 |
Why?
|
| Binding Sites | 1 | 2017 | 1167 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 320 | 0.110 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2014 | 24 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2014 | 37 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1429 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2015 | 231 | 0.100 |
Why?
|
| Vaccines, Subunit | 1 | 2013 | 55 | 0.100 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 45 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 66 | 0.100 |
Why?
|
| Nanofibers | 1 | 2013 | 32 | 0.100 |
Why?
|
| CD40 Ligand | 1 | 2013 | 77 | 0.100 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 48 | 0.100 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 65 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2013 | 446 | 0.100 |
Why?
|
| Transplantation, Homologous | 4 | 2017 | 1023 | 0.090 |
Why?
|
| Neutrophils | 2 | 2012 | 332 | 0.090 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 173 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2013 | 278 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 174 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2013 | 267 | 0.090 |
Why?
|
| Interferon-gamma | 3 | 2020 | 467 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 307 | 0.090 |
Why?
|
| Interleukin-7 | 1 | 2012 | 47 | 0.090 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 99 | 0.090 |
Why?
|
| Phenotype | 2 | 2016 | 2579 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 684 | 0.090 |
Why?
|
| Mathematical Computing | 1 | 2011 | 21 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2777 | 0.090 |
Why?
|
| Myeloid Cells | 1 | 2012 | 121 | 0.090 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2011 | 35 | 0.090 |
Why?
|
| Systems Biology | 1 | 2011 | 47 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 701 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 164 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 672 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2012 | 489 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2550 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 750 | 0.070 |
Why?
|
| Cell Movement | 2 | 2017 | 816 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 2090 | 0.060 |
Why?
|
| Lung | 1 | 2013 | 1382 | 0.060 |
Why?
|
| Male | 7 | 2020 | 45870 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2940 | 0.060 |
Why?
|
| Endocytosis | 2 | 2017 | 186 | 0.060 |
Why?
|
| Female | 7 | 2020 | 50030 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 1051 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.050 |
Why?
|
| Germ Cells | 1 | 2005 | 134 | 0.050 |
Why?
|
| Models, Biological | 1 | 2011 | 1810 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 123 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 100 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 162 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 116 | 0.050 |
Why?
|
| CD18 Antigens | 1 | 2023 | 22 | 0.050 |
Why?
|
| Genome | 1 | 2006 | 407 | 0.050 |
Why?
|
| Algorithms | 1 | 2011 | 2014 | 0.050 |
Why?
|
| Body Patterning | 1 | 2005 | 217 | 0.050 |
Why?
|
| Cytokines | 2 | 2020 | 872 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2004 | 433 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 124 | 0.050 |
Why?
|
| Lymphoma | 1 | 2004 | 271 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2022 | 88 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 93 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 9173 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 150 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 104 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2004 | 483 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 110 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1828 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1332 | 0.040 |
Why?
|
| Peptidoglycan | 1 | 2020 | 31 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 212 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 719 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2020 | 284 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 18 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1998 | 18 | 0.040 |
Why?
|
| Monocytes | 1 | 2020 | 231 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 1998 | 32 | 0.040 |
Why?
|
| Inflammation | 3 | 2013 | 1068 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 305 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1998 | 49 | 0.040 |
Why?
|
| CHO Cells | 1 | 1998 | 196 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 1238 | 0.040 |
Why?
|
| Clone Cells | 1 | 1998 | 223 | 0.040 |
Why?
|
| Viruses | 1 | 1999 | 75 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 1998 | 96 | 0.040 |
Why?
|
| Virus Diseases | 1 | 1999 | 102 | 0.030 |
Why?
|
| Cricetinae | 1 | 1998 | 542 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 16 | 0.030 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2017 | 54 | 0.030 |
Why?
|
| Granzymes | 1 | 2017 | 96 | 0.030 |
Why?
|
| Keratitis, Herpetic | 1 | 1997 | 10 | 0.030 |
Why?
|
| Trigeminal Ganglion | 1 | 1997 | 16 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2017 | 95 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 101 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 110 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 67 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 69 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 145 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Virus Replication | 1 | 1997 | 326 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 873 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2014 | 77 | 0.030 |
Why?
|
| Schistosomiasis | 1 | 1994 | 5 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1546 | 0.030 |
Why?
|
| Thy-1 Antigens | 1 | 1994 | 16 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1994 | 113 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 99 | 0.030 |
Why?
|
| Protein Kinase C-theta | 1 | 2013 | 16 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2013 | 42 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1994 | 85 | 0.030 |
Why?
|
| Arthritis | 1 | 1994 | 53 | 0.030 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 75 | 0.030 |
Why?
|
| Listeriosis | 1 | 1994 | 90 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 81 | 0.020 |
Why?
|
| Mites | 1 | 2013 | 17 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1994 | 242 | 0.020 |
Why?
|
| Spleen | 1 | 2014 | 439 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 93 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 185 | 0.020 |
Why?
|
| Epitopes | 1 | 2013 | 258 | 0.020 |
Why?
|
| Rituximab | 1 | 2013 | 133 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2012 | 34 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 439 | 0.020 |
Why?
|
| Complement C4b | 1 | 2012 | 33 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2012 | 18 | 0.020 |
Why?
|
| CD3 Complex | 1 | 2012 | 136 | 0.020 |
Why?
|
| Interleukins | 1 | 2013 | 134 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 29 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 201 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 348 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2013 | 166 | 0.020 |
Why?
|
| Collagen | 1 | 1994 | 307 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2011 | 18 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 48 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 1882 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 279 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 289 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2012 | 183 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 180 | 0.020 |
Why?
|
| Base Sequence | 1 | 1994 | 2344 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 155 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 922 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 469 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 901 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3040 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 706 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1220 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 992 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 398 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5585 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 191 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2006 | 97 | 0.020 |
Why?
|
| Limb Buds | 1 | 2005 | 7 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 4671 | 0.010 |
Why?
|
| Branchial Region | 1 | 2005 | 15 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 563 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 438 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 503 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 599 | 0.010 |
Why?
|
| Middle Aged | 2 | 2014 | 28361 | 0.010 |
Why?
|
| Adult | 2 | 2014 | 28716 | 0.010 |
Why?
|
| Placenta | 1 | 2005 | 191 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 553 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 294 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 626 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 21 | 0.010 |
Why?
|
| Lymphokines | 1 | 1995 | 75 | 0.010 |
Why?
|
| CD28 Antigens | 1 | 1995 | 94 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 86 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 368 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 1995 | 184 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 209 | 0.010 |
Why?
|
| Immunity | 1 | 1995 | 157 | 0.010 |
Why?
|